サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1607750

定量吸入器の世界市場：製品・プロペラント・技術・適応症・流通チャネル・地域別の予測 (～2032年)

Global Metered Dose Inhalers Market Research Report Information By Product, By Propellant Type, By Technology, By Indication, By Distribution Channel And By Region Forecast Till 2032

出版日
ページ情報
英文 151 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
定量吸入器の世界市場：製品・プロペラント・技術・適応症・流通チャネル・地域別の予測 (～2032年)
出版日: 2024年11月21日
発行: Market Research Future
ページ情報: 英文 151 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の定量吸入器の市場規模は、2023年の158億米ドル、2024年の171億米ドルから、予測期間中は6.43％のCAGRで推移し、2032年には300億米ドルの規模に成長すると予測されています。世界の定量吸入器の市場は、呼吸器疾患の有病率の増加、参入企業による新製品の発売、一般の意識と教育の高まりにより成長が進んでいます。

世界の定量吸入器の市場は、新しい製品のアベイラビリティの拡大により大きな成長を経験しています。ドラッグデリバリーシステムの改善や人間工学に基づいたデザインなど、これらの発売がもたらす技術的進歩は、使いやすさや服薬アドヒアランスといった患者の要望に合わせたものです。革新的な製剤と組み合わせは、多様な呼吸器疾患に対する新たな治療の選択肢を提供し、治療効果と患者の転帰の質を向上させます。

地域別展望

2023年の市場シェアでは北米がもっとも大きく、アジア太平洋は予測期間中にもっとも高いCAGRを示すと予測されています。

北米の定量吸入器市場は、支持的な規制環境、技術の進歩、ヘルスケア要件の増加によって特徴付けられ、これらすべてが堅調な成長を促進しています。さらに、同地域市場は最先端の定量吸入器の開発によって牽引されており、これは研究開発への多額の投資と高度な医療インフラによって可能となっています。

欧州の定量吸入器市場は、確立された医療インフラと医療支出の増加を特徴としています。

予測期間中、アジア太平洋地域は、さまざまな要因に牽引され、堅調な開発が予想されています。また、もっとも急成長している地域でもあると予測されています。高度な吸入器の需要は、中国、インド、日本などの国における医療インフラの急速な拡大や医療インフラへの投資の増加によって牽引されています。

当レポートでは、世界の定量吸入器の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

  • 促進要因
    • 参入企業による製品発売の増加
    • 意識と教育の高まり
  • 抑制要因
    • 市参入企業による自主的な製品回収
    • 厳格な規制政策
  • 機会
    • 民間および公的機関による投資の増加
    • 定量吸入器に関する進行中の臨床試験

第5章 市場要因分析

  • ポーターのファイブフォース分析
  • COVID-19が世界の定量吸入器市場に与える影響
  • 世界の定量吸入器市場の主な動向

第6章 世界の定量吸入器市場：製品別

  • 概要
  • プレス式
  • 呼吸作動式

第7章 世界の定量吸入器市場：プロペラント別

  • 概要
  • HFA 134A
  • HFA 227EA
  • HFA 152A

第8章 世界の定量吸入器市場：技術別

  • 概要
  • 肺プラットフォーム技術
  • 鼻腔プラットフォーム技術

第9章 世界の定量吸入器市場：適応症別

  • 概要
  • 喘息
  • 慢性閉塞性肺疾患
  • その他

第10章 世界の定量吸入器市場：流通チャネル別

  • 概要
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第11章 世界の定量吸入器市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他
  • その他の地域
    • 中東・アフリカ
    • 南米

第12章 競合情勢

  • 市場シェア分析
  • 競合ダッシュボード
  • 公開企業の株式概要
  • 比較分析：主要企業の財務
  • 主な展開・成長戦略

第13章 企業プロファイル

  • ASTRAZENECA
  • GSK PLC
  • ORGANON GROUP OF COMPANIES
  • CIPLA INC.
  • LUPIN PHARMACEUTICALS, INC.
  • ZYDUS GROUP
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • VIATRIS INC.
  • ARISTOPHARMA LTD.
  • BEXIMCO PHARMACEUTICALS LTD.
図表

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 4 GLOBAL METERED DOSE INHALERS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL METERED DOSE INHALERS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019-2032 (UNITS)
  • TABLE 6 GLOBAL METERED DOSE INHALERS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL METERED DOSE INHALERS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019-2032 (UNITS)
  • TABLE 8 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2019-2032 (UNITS)
  • TABLE 10 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (UNITS)
  • TABLE 12 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (UNITS)
  • TABLE 14 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA-152A, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA-152A, BY REGION, 2019-2032 (UNITS)
  • TABLE 16 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 18 GLOBAL METERED DOSE INHALERS MARKET, FOR PULMONARY PLATFORM TECHNOLOGIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 19 GLOBAL METERED DOSE INHALERS MARKET, FOR PULMONARY PLATFORM TECHNOLOGIES, BY REGION, 2019-2032 (UNITS)
  • TABLE 20 GLOBAL METERED DOSE INHALERS MARKET, FOR NASAL PLATFORM TECHNOLOGIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 21 GLOBAL METERED DOSE INHALERS MARKET, FOR NASAL PLATFORM TECHNOLOGIES, BY REGION, 2019-2032 (UNITS)
  • TABLE 22 GLOBAL METERED DOSE INHALERS MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 23 GLOBAL METERED DOSE INHALERS MARKET, FOR ASTHMA, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 24 GLOBAL METERED DOSE INHALERS MARKET, FOR COPD, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 25 GLOBAL METERED DOSE INHALERS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 26 GLOBAL METERED DOSE INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 27 GLOBAL METERED DOSE INHALERS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 28 GLOBAL METERED DOSE INHALERS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 29 GLOBAL METERED DOSE INHALERS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 30 GLOBAL METERED DOSE INHALER MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 31 NORTH AMERICA: METERED DOSE INHALER MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 32 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 33 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 34 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 35 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 36 NORTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 37 NORTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 38 NORTH AMERICA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 39 NORTH AMERICA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 40 US: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 41 US: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 42 US: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 43 US: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 44 US: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 45 US: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 46 US: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 47 US: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 48 US: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 49 CANADA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 50 CANADA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 51 CANADA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 52 CANADA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 53 CANADA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 54 CANADA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 55 CANADA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 56 CANADA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 57 CANADA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 58 EUROPE: METERED DOSE INHALER MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 59 EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 60 EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 61 EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 62 EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 63 EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 64 EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 65 EUROPE: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 66 EUROPE: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 67 GERMANY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 68 GERMANY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 69 GERMANY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 70 GERMANY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 71 GERMANY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 72 GERMANY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 73 GERMANY: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 74 GERMANY: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 75 FRANCE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 76 FRANCE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 77 FRANCE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 78 FRANCE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 79 FRANCE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 80 FRANCE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 81 FRANCE: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 82 FRANCE: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 83 UK: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 84 UK: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 85 UK: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 86 UK: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 87 UK: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 88 UK: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 89 UK: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 90 UK: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 91 ITALY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 92 ITALY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 93 ITALY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 94 ITALY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 95 ITALY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 96 ITALY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 97 ITALY: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 98 ITALY: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 99 SPAIN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 100 SPAIN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 101 SPAIN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 102 SPAIN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 103 SPAIN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 104 SPAIN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 105 SPAIN: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 106 SPAIN: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 107 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 108 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 109 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 110 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 111 REST OF EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 112 REST OF EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 113 REST OF EUROPE: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 114 REST OF EUROPE: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 115 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 116 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 117 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 118 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 119 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 120 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 121 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 122 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 123 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 124 CHINA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 125 CHINA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 126 CHINA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 127 CHINA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 128 CHINA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 129 CHINA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 130 CHINA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 131 CHINA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 132 INDIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 133 INDIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 134 INDIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 135 INDIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 136 INDIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 137 INDIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 138 INDIA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 139 INDIA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 140 JAPAN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 141 JAPAN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 142 JAPAN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 143 JAPAN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 144 JAPAN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 145 JAPAN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 146 JAPAN: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 147 JAPAN: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 148 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 149 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 150 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 151 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 152 SOUTH KOREA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 153 SOUTH KOREA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 154 SOUTH KOREA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 155 SOUTH KOREA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 156 AUSTRALIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 157 AUSTRALIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 158 AUSTRALIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 159 AUSTRALIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 160 AUSTRALIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 161 AUSTRALIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 162 AUSTRALIA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 163 AUSTRALIA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 164 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 165 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 166 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 167 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 168 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 169 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 170 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 171 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 172 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 173 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 174 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 175 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 176 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 177 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 178 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 179 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 180 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 181 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 182 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 183 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 184 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 185 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 186 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 187 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 188 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 189 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 190 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 191 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019-2032 (UNITS)
  • TABLE 192 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (USD MILLION)
  • TABLE 193 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019-2032 (UNITS)
  • TABLE 194 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 195 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019-2032 (UNITS)
  • TABLE 196 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY INDICATION, 2019-2032 (USD MILLION)
  • TABLE 197 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 198 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 199 PARTNERSHIP
  • TABLE 200 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 201 ASTRAZENECA: PRODUCT OFFERED
  • TABLE 202 ASTRAZENECA: KEY DEVELOPMENTS
  • TABLE 203 GSK PLC: PRODUCTS OFFERED
  • TABLE 204 ORGANON GROUP OF COMPANIES: PRODUCT OFFERED
  • TABLE 205 CIPLA INC.: PRODUCT OFFERED
  • TABLE 206 CIPLA INC.: KEY DEVELOPMENTS
  • TABLE 207 LUPIN PHARMACEUTICALS, INC.: PRODUCTS OFFERED
  • TABLE 208 LUPIN PHARMACEUTICALS, INC.: KEY DEVELOPMENTS
  • TABLE 209 ZYDUS GROUP: PRODUCTS OFFERED
  • TABLE 210 ZYDUS GROUP: KEY DEVELOPMENTS
  • TABLE 211 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED
  • TABLE 212 VIATRIS INC.: PRODUCTS OFFERED
  • TABLE 213 ARISTOPHARMA LTD.: PRODUCTS OFFERED
  • TABLE 214 BEXIMCO PHARMACEUTICALS LTD.: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL METERED DOSE INHALER MARKET: STRUCTURE
  • FIGURE 2 GLOBAL METERED DOSE INHALERS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL METERED DOSE INHALERS MARKET
  • FIGURE 6 GLOBAL METERED DOSE INHALERS MARKET, PRODUCT, 2023 & 2032 (USD MILLION)
  • FIGURE 7 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY PRODUCT,
  • FIGURE 9 GLOBAL METERED DOSE INHALERS MARKET, PROPELLANT TYPE, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2023 & 2032 (USD MILLION)
  • FIGURE 11 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY PROPELLANT TYPE,
  • FIGURE 12 GLOBAL METERED DOSE INHALERS MARKET, TECHNOLOGY, 2023 & 2032 (USD MILLION)
  • FIGURE 13 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION)
  • FIGURE 14 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY TECHNOLOGY,
  • FIGURE 15 GLOBAL METERED DOSE INHALERS MARKET, INDICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 16 GLOBAL METERED DOSE INHALERS MARKET, BY INDICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 17 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY INDICATION,
  • FIGURE 18 GLOBAL METERED DOSE INHALERS MARKET, DISTRIBUTION CHANNEL, 2023 & 2032 (USD MILLION)
  • FIGURE 19 GLOBAL METERED DOSE INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2023 & 2032 (USD MILLION)
  • FIGURE 20 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY DISTRIBUTION CHANNEL,
  • FIGURE 21 GLOBAL METERED DOSE INHALER MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 22 GLOBAL METERED DOSE INHALER MARKET SHARE, BY REGION, 2023 (% SHARE)
  • FIGURE 23 NORTH AMERICA MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 24 NORTH AMERICA METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 25 NORTH AMERICA METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 26 EUROPE MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 27 EUROPE METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 28 EUROPE METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 29 ASIA-PACIFIC MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 30 ASIA-PACIFIC METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 31 ASIA-PACIFIC METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 32 REST OF THE WORLD MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 33 REST OF THE WORLD METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 34 REST OF THE WORLD METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 35 GLOBAL METERED DOSE INHALER MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 36 COMPETITOR DASHBOARD: GLOBAL METERED DOSE INHALER MARKET
  • FIGURE 37 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 ASTRAZENECA: SWOT ANALYSIS
  • FIGURE 39 GSK PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 40 GSK PLC: SWOT ANALYSIS
  • FIGURE 41 ORGANON GROUP OF COMPANIES: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 42 CIPLA INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 CIPLA INC.: SWOT ANALYSIS
  • FIGURE 44 LUPIN PHARMACEUTICALS, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 45 LUPIN PHARMACEUTICALS, INC.: SWOT ANALYSIS
  • FIGURE 46 ZYDUS GROUP: FINANCIAL OVERVIEW
  • FIGURE 47 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 48 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
  • FIGURE 49 VIATRIS INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 50 VIATRIS INC.: SWOT ANALYSIS
  • FIGURE 51 BEXIMCO PHARMACEUTICALS LTD.: FINANCIAL OVERVIEW SNAPSHOT
目次
Product Code: MRFR/HC/26937-CR

Global Metered Dose Inhalers Market Research Report Information By Product (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By Propellant Type (HFA 134A, HFA 227EA, HFA 152A), By Technology (Pulmonary Platform Technologies, Nasal Platform Technologies), By Indication (Asthma, COPD, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Forecast Till 2032

Market Overview

In 2023, the Metered Dose Inhalers Market was estimated to be worth USD 15.8 billion. Over the forecast period (2024-2032), the industry is anticipated to expand from USD 17.1 billion in 2024 to USD 30.0 billion by 2032, with a compound annual growth rate (CAGR) of 6.43%. The global metered-dose inhaler market is experiencing development due to the increasing prevalence of respiratory diseases, the launch of new products by market players, and the increasing awareness and education of the public.

The global MDI market is experiencing significant growth due to the increasing availability of new metered dose inhaler (MDI) products. The technological advancements that these launches bring about, such as improved drug delivery systems and ergonomic designs, are tailored to the preferences of patients for simplicity of use and adherence. Innovative formulations and combinations provide additional therapeutic options for a diverse array of respiratory conditions, thereby enhancing the efficacy of treatment and the quality of patient outcomes.

Market segment insights

The Metered Dose Inhalers Market has been segmented into Press Metered Dose Inhalers and Breath actuated Metered Dose Inhalers based on product.

The Metered Dose Inhalers Market has been segmented into HFA 134a, HFA 227ea, and HFA-152a based on propellant type.

The Metered Dose Inhalers Market has been segmented into pulmonary platform technologies and nasal platform technologies based on technology.

Metered Dose Inhalers Market has been segmented into Asthma, COPD, and other categories based on indication.

Hospital pharmacies, retail pharmacies, and online pharmacies comprise the Metered Dose Inhalers Market, contingent upon their distribution channels.

Regional Perspectives

In 2023, the market share that North America possessed was the most significant. Nevertheless, Asia-Pacific is anticipated to experience the most significant compound annual growth rate (CAGR) during the 2024-2032 forecast period.

The Metered Dose Inhalers market in North America is distinguished by a supportive regulatory environment, technological advancements, and increased healthcare requirements, all of which are driving robust growth. Additionally, the market is driven by the development of state-of-the-art Metered Dose Inhalers, which is made possible by a substantial investment in research and development and a sophisticated healthcare infrastructure.

Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe, follows the Americas region. The Metered Dose Inhalers market in Europe is characterized by a well-established healthcare infrastructure and an increase in healthcare expenditure.

Over the forecast period, the Asia-Pacific region is anticipated to experience robust development, which is driven by a variety of key factors. It is also projected to be the fastest-growing region. The demand for sophisticated inhalers is being driven by the rapid expansion of healthcare infrastructure and the increasing investments in healthcare infrastructure in countries such as China, India, and Japan.

Major Players

AstraZeneca (UK), GSK PLC. (UK), Organon (US), Cipla, Inc. (India), Lupin Pharmaceuticals, Inc. (India), Zydus Group (India), Teva Pharmaceutical Industries Ltd. (Israel), Viatris Inc. (US), Aristopharma Ltd. (Bangladesh), and Beximco Pharmaceuticals Limited (Bangladesh) are among the key companies in the Metered Dose Inhalers Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TYPE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING PRODUCT LAUNCH BY MARKET PLAYERS
    • 4.2.2 GROWING AWARENESS AND EDUCATION
  • 4.3 RESTRAINTS
    • 4.3.1 VOLUNTARY PRODUCT RECALL FROM MARKET PLAYERS
    • 4.3.2 STRINGENT REGULATORY POLICIES
  • 4.4 OPPORTUNITY
    • 4.4.1 INCREASING INVESTMENT BY PRIVATE AND PUBLIC ORGANIZATION
    • 4.4.2 ONGOING CLINICAL TRIALS ASSOCIATED WITH METERED DOSE INHALER

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 IMPACT OF COVID-19 ON THE GLOBAL METERED DOSE INHALERS MARKET
  • 5.3 KEY TRENDS FOR GLOBAL METERED DOSE INHALERS MARKET

6 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 PRESS METERED DOSE INHALERS
  • 6.3 BREATH ACTUATED METERED DOSE INHALERS

7 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE

  • 7.1 OVERVIEW
  • 7.2 HFA 134A
  • 7.3 HFA 227EA
  • 7.4 HFA-152A

8 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY

  • 8.1 OVERVIEW
  • 8.2 PULMONARY PLATFORM TECHNOLOGIES
  • 8.3 NASAL PLATFORM TECHNOLOGIES

9 GLOBAL METERED DOSE INHALERS MARKET, BY INDICATION

  • 9.1 OVERVIEW
  • 9.2 ASTHMA
  • 9.3 COPD
  • 9.4 OTHERS

10 GLOBAL METERED DOSE INHALERS MARKET, BY DISTRIBUTION CHANNEL

  • 10.1 OVERVIEW
  • 10.2 HOSPITAL PHARMACIES
  • 10.3 RETAIL PHARMACIES
  • 10.4 ONLINE PHARMACIES

11 GLOBAL METERED DOSE INHALER MARKET, BY REGION

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 US
    • 11.2.2 CANADA
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 FRANCE
    • 11.3.3 UK
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 INDIA
    • 11.4.3 JAPAN
    • 11.4.4 SOUTH KOREA
    • 11.4.5 AUSTRALIA
    • 11.4.6 REST OF ASIA-PACIFIC
  • 11.5 REST OF THE WORLD
    • 11.5.1 MIDDLE EAST & AFRICA
    • 11.5.2 SOUTH AMERICA

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 MARKET SHARE ANALYSIS,
  • 12.3 COMPETITOR DASHBOARD
  • 12.4 PUBLIC PLAYERS STOCK SUMMARY
  • 12.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 12.6.1 PARTNERSHIP
    • 12.6.2 PRODUCT LAUNCH/PRODUCT APPROVAL

13 COMPANY PROFILES

  • 13.1 ASTRAZENECA
    • 13.1.1 COMPANY OVERVIEW
    • 13.1.2 FINANCIAL OVERVIEW
    • 13.1.3 PRODUCTS OFFERED
    • 13.1.4 KEY DEVELOPMENTS
    • 13.1.5 SWOT ANALYSIS
    • 13.1.6 KEY STRATEGIES
  • 13.2 GSK PLC
    • 13.2.1 COMPANY OVERVIEW
    • 13.2.2 FINANCIAL OVERVIEW
    • 13.2.3 PRODUCT OFFERED
    • 13.2.4 KEY DEVELOPMENTS
    • 13.2.5 SWOT ANALYSIS
    • 13.2.6 KEY STRATEGIES
  • 13.3 ORGANON GROUP OF COMPANIES
    • 13.3.1 COMPANY OVERVIEW
    • 13.3.2 FINANCIAL OVERVIEW
    • 13.3.3 PRODUCTS OFFERED
    • 13.3.4 KEY DEVELOPMENTS
    • 13.3.5 KEY STRATEGIES
  • 13.4 CIPLA INC.
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 FINANCIAL OVERVIEW
    • 13.4.3 PRODUCTS OFFERED
    • 13.4.4 KEY DEVELOPMENTS
    • 13.4.5 SWOT ANALYSIS
    • 13.4.6 KEY STRATEGIES
  • 13.5 LUPIN PHARMACEUTICALS, INC.
    • 13.5.1 COMPANY OVERVIEW
    • 13.5.2 FINANCIAL OVERVIEW
    • 13.5.3 PRODUCT OFFERED
    • 13.5.4 KEY DEVELOPMENTS
    • 13.5.5 SWOT ANALYSIS
    • 13.5.6 KEY STRATEGIES
  • 13.6 ZYDUS GROUP
    • 13.6.1 COMPANY OVERVIEW
    • 13.6.2 FINANCIAL OVERVIEW
    • 13.6.3 PRODUCTS OFFERED
    • 13.6.4 KEY DEVELOPMENTS
    • 13.6.5 KEY STRATEGIES
  • 13.7 TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • 13.7.1 COMPANY OVERVIEW
    • 13.7.2 FINANCIAL OVERVIEW
    • 13.7.3 PRODUCTS OFFERED
    • 13.7.4 KEY DEVELOPMENTS
    • 13.7.5 SWOT ANALYSIS
    • 13.7.6 KEY STRATEGIES
  • 13.8 VIATRIS INC.
    • 13.8.1 COMPANY OVERVIEW
    • 13.8.2 FINANCIAL OVERVIEW
    • 13.8.3 PRODUCTS OFFERED
    • 13.8.4 KEY DEVELOPMENTS
    • 13.8.5 SWOT ANALYSIS
    • 13.8.6 KEY STRATEGIES
  • 13.9 ARISTOPHARMA LTD.
    • 13.9.1 COMPANY OVERVIEW
    • 13.9.2 FINANCIAL OVERVIEW
    • 13.9.3 PRODUCT OFFERED
    • 13.9.4 KEY DEVELOPMENTS

SOURCE: ANNUAL REPORT AND PRESS RELEASES

    • 13.9.5 KEY STRATEGIES
  • 13.10 BEXIMCO PHARMACEUTICALS LTD.
    • 13.10.1 COMPANY OVERVIEW
    • 13.10.2 FINANCIAL OVERVIEW
    • 13.10.3 PRODUCTS OFFERED
    • 13.10.4 KEY DEVELOPMENTS
    • 13.10.5 KEY STRATEGIES
  • 13.11 DATA CITATIONS